A research team from NUST MISIS and Pirogov Russian National Research Medical University (RNRMU) has successfully conducted preclinical trials of a new anticancer drug based on magnetite nanoparticles. In the test results, the lifetime of sick mice who were given the drug was doubled. The research results have been published in Nanomedicine.
NUST MISIS will create a National Center of Technological Initiative for end-to-end “Quantum Communication” technology. The University won the Russian Venture Company contest, which was held with the Russian government’s support for the National Center of Technological Initiative. The Center’s planned financing is approximately 2 billion Rubles from now to 2020.
NUST MISIS has significantly improved its position in the Times Higher Education (THE) Emerging Economies University Rankings, rising from 163rd to 99th. The University has shown excellent results despite increasing competition: in 2014, representatives of 20 different countries participated in the ranking, but in 2018 that number increased to 50.
The Russian Federal Service for Intellectual Property (Rospatent) recognized the Russian Federation patent 2625832 as patent of the week (April 30th, 2018 to May 6th, 2018). This patent is NUST MISIS`s “Drill bit reinforced with diamond-cutting elements” development (authors: Polushin N.I., Maslov A.L., Laptev A.I., Kushkhabiev A.S., Kotelnikova O.S., Varshavskiy Y.S.).